- Full text PDF available (1)
Atracurium was used to produce neuromuscular blockade in a patient with dystrophia myotonica. Operating conditions were excellent and myotonia was not seen. Sensitivity to atracurium was not seen and spontaneous recovery was not prolonged.
Patients in clinical practice and participants in clinical trials are warned about side effects that may result from their treatment. Such warnings could lead to placebo-induced side effects if they create an expectation of these effects. We used an experimental model to test this possibility. Undergraduates reporting sleep difficulty received placebo… (More)